View Financial HealthGreen Oleo 配当と自社株買い配当金 基準チェック /06Green Oleo配当金を支払った記録がありません。主要情報n/a配当利回り-3.9%バイバック利回り総株主利回り-3.9%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesBoard Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Standing Auditor Paola Mignani was the last director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 17Green Oleo S.p.A., Annual General Meeting, Apr 30, 2026Green Oleo S.p.A., Annual General Meeting, Apr 30, 2026, at 14:30 W. Europe Standard Time. Location: via santa marta n 19, milano Italyお知らせ • Apr 15Green Oleo S.p.A., Annual General Meeting, Apr 29, 2025Green Oleo S.p.A., Annual General Meeting, Apr 29, 2025, at 09:00 W. Europe Standard Time.Reported Earnings • Oct 04First half 2024 earnings releasedFirst half 2024 results: EPS: €0.002. Net income: €77.4k (up €77.4k from 1H 2023). Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany.New Risk • Aug 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (14% operating cash flow to total debt). Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Market cap is less than US$100m (€28.8m market cap, or US$31.5m).Reported Earnings • Apr 25Full year 2023 earnings releasedFull year 2023 results: Revenue: €65.2m (down 22% from FY 2022). Net loss: €590.7k (down 111% from profit in FY 2022). Revenue is forecast to grow 8.4% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany.New Risk • Apr 17New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 37% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (14% operating cash flow to total debt). Earnings are forecast to decline by an average of 37% per year for the foreseeable future. High level of non-cash earnings (26% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Market cap is less than US$100m (€31.2m market cap, or US$33.2m).Buy Or Sell Opportunity • Jan 31Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 3.6% to €1.01. The fair value is estimated to be €0.83, however this is not to be taken as a sell recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 9.5% per annum. Earnings are also forecast to grow by 2.5% per annum over the same time period.Board Change • Jul 26Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. President, CEO & Director Beatrice Buzzella was the last director to join the board, commencing their role in 2012. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.決済の安定と成長配当データの取得安定した配当: 77Mの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: 77Mの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Green Oleo 配当利回り対市場77M 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (77M)n/a市場下位25% (DE)1.5%市場トップ25% (DE)4.7%業界平均 (Chemicals)3.9%アナリスト予想 (77M) (最長3年)n/a注目すべき配当: 77Mは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: 77Mは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: 77Mの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: 77Mが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YDE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/09 05:25終値2026/06/09 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Green Oleo S.p.A. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関null nullIntermonte SIM S.p.A.Silvestro BonoraIntermonte SIM S.p.A.Federico ZangaroIR Top Consulting S.r.l.
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Standing Auditor Paola Mignani was the last director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 17Green Oleo S.p.A., Annual General Meeting, Apr 30, 2026Green Oleo S.p.A., Annual General Meeting, Apr 30, 2026, at 14:30 W. Europe Standard Time. Location: via santa marta n 19, milano Italy
お知らせ • Apr 15Green Oleo S.p.A., Annual General Meeting, Apr 29, 2025Green Oleo S.p.A., Annual General Meeting, Apr 29, 2025, at 09:00 W. Europe Standard Time.
Reported Earnings • Oct 04First half 2024 earnings releasedFirst half 2024 results: EPS: €0.002. Net income: €77.4k (up €77.4k from 1H 2023). Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany.
New Risk • Aug 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (14% operating cash flow to total debt). Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Market cap is less than US$100m (€28.8m market cap, or US$31.5m).
Reported Earnings • Apr 25Full year 2023 earnings releasedFull year 2023 results: Revenue: €65.2m (down 22% from FY 2022). Net loss: €590.7k (down 111% from profit in FY 2022). Revenue is forecast to grow 8.4% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany.
New Risk • Apr 17New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 37% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (14% operating cash flow to total debt). Earnings are forecast to decline by an average of 37% per year for the foreseeable future. High level of non-cash earnings (26% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Market cap is less than US$100m (€31.2m market cap, or US$33.2m).
Buy Or Sell Opportunity • Jan 31Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 3.6% to €1.01. The fair value is estimated to be €0.83, however this is not to be taken as a sell recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 9.5% per annum. Earnings are also forecast to grow by 2.5% per annum over the same time period.
Board Change • Jul 26Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. President, CEO & Director Beatrice Buzzella was the last director to join the board, commencing their role in 2012. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.